Patents Represented by Attorney, Agent or Law Firm Deanna L. Baxam
-
Patent number: 7105677Abstract: Provided are processes and synthetic intermediates useful for the preparation of azaindole piperazine diamide derivatives of the formula These azaindole piperazine diamide derivatives, among other things, are useful as therapeutic agents for the treatment of HIV and AIDS.Type: GrantFiled: September 23, 2004Date of Patent: September 12, 2006Assignee: Bristol-Myers Squibb CompanyInventors: Nachimuthu Soundararajan, Serge Benoit, Stephane Gingres
-
Patent number: 7070751Abstract: The present invention provides a reactor for the gas-phase reaction of commercially available gases in the presence of an inert carrier gas to form product gas. The reactor has a streamlined, compact configuration and at least one solids collection and removal system downstream of the reactor, where solids are efficiently removed from the product gas stream, leaving high purity product gas. The removal system allows for a simple reactor design, which is easy to clean and operates continuously over longer periods of time.Type: GrantFiled: November 14, 2003Date of Patent: July 4, 2006Assignee: Bristol-Myers Squibb Co.Inventors: Srinivas Tummala, Shun Wang Leung, Ehrlic T. Lo, Mario Moisés Alvarez
-
Patent number: 7005436Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.Type: GrantFiled: April 16, 2003Date of Patent: February 28, 2006Assignees: Bristol Myers Squibb Company, Icagen, Inc.Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
-
Patent number: 6968037Abstract: Multiple samples are prepared in slurry form and deposited through a funnel plate by a multiprobe liquid handler into an array of inserts situated in openings in a housing. Each insert has a recess that extends through the insert body and a filter disc situated in the recess to support the sample. The filter is held in place by an annular part which defines a channel providing access to the filter through the lower portion of the recess. A pressure differential is created across each of the filters by attaching a vacuum manifold to the bottom of the housing to simultaneously remove the liquid from each of the samples, leaving the samples in powder form. The housing is then placed in the X-ray diffractometer for sequential analysis of each of the samples, while the samples are situated in the inserts.Type: GrantFiled: April 10, 2003Date of Patent: November 22, 2005Assignee: Bristol-Myers Squibb Co.Inventors: Victor W. Rosso, Glen Young, Joseph Nolfo, Imre M. Vit z, John J. Venit
-
Patent number: 6930187Abstract: An improved method of synthesis of 21-amino epothilone derivatives which provides a one-pot conversion of 21-hydroxy epothilones to highly desirable 21-amino epothilones in high yield.Type: GrantFiled: February 13, 2003Date of Patent: August 16, 2005Assignee: Bristol-Myers Squibb CompanyInventors: Denis Favreau, Joydeep Kant, Kathia Levesque, Shaopeng Wang, Zhengrong Guo, Brian Leslie James
-
Patent number: 6884889Abstract: Provided are processes and synthetic intermediates useful for the preparation of azaindole piperazine diamide derivatives of the formula These azaindole piperazine diamide derivatives, among other things, are useful as therapeutic agents for the treatment of HIV and AIDS.Type: GrantFiled: March 24, 2003Date of Patent: April 26, 2005Assignee: Bristol-Myers Squibb Co.Inventors: Nachimuthu Soundararajan, Serge Benoit, Stephane Gingras
-
Patent number: 6881753Abstract: Indanes, benzopyrans and analogues thereof are potassium channel inhibitors and blockers of IKur and have the structure: where A, B, D, Q, X1, R, R1, X2 and R2 are as defined herein. These compounds are useful as antiarrhythmic agents. In addition, a method is provided for preventing cardiac arrhythmia employing the above compounds.Type: GrantFiled: April 14, 2004Date of Patent: April 19, 2005Assignee: Bristol-Myers Squibb Co.Inventors: John Lloyd, Heather J. Finlay, Wayne Vaccaro, Karnail S. Atwal, Michael F. Gross, Kerry L. Spear
-
Patent number: 6858644Abstract: Biologically active crystalline solvates of paclitaxel are precipitated using polar, aprotic, organic solvents. A pharmaceutical composition is also disclosed, as well as the preparation of the novel solvates and their uses as anti-tumor agents.Type: GrantFiled: November 26, 2002Date of Patent: February 22, 2005Assignee: Bristol-Myers Squibb Co.Inventors: Daniel A. Benigni, Jack Z. Gougoutas, John D. DiMarco
-
Patent number: 6806381Abstract: Provided are processes for the synthesis of aniline derivatives, specifically certain aniline derivatives which have activity as thyroid receptor ligands.Type: GrantFiled: October 17, 2002Date of Patent: October 19, 2004Assignee: Bristol-Myers Squibb CompanyInventors: Ramakrishnan Chidambaram, Joydeep Kant, Raymond E. Weaver, Jurong Yu, Arun Ghosh
-
Patent number: 6800477Abstract: The present invention is directed to novel stereoselective processes for the preparation of (S)-1-arylethanols by the reduction of the corresponding keto group containing compounds by microorganisms. (S)-1-arylethanols are useful as intermediates in the synthesis of compounds that are inhibitors of &ggr;-secretase useful in the treatment of Alzheimer's disease.Type: GrantFiled: March 6, 2002Date of Patent: October 5, 2004Assignee: Bristol-Myers Squibb Co.Inventors: Ramesh Patel, Animesh Goswami, Linda N. Chu, Venkata B. Nanduri, Steven L. Goldberg, Robert M. Johnston, Mary Jo Donovan, K. David Mirfakhrae
-
Patent number: 6784189Abstract: Indanes, benzopyrans and analogues thereof are potassium channel inhibitors and blockers of IKur and have the structure where A, B, D, Q, X1, R, R1, X2 and R2 are as defined herein. These compounds are useful as antiarrhythmic agents. In addition, a method is provided for preventing cardiac arrhythmia employing the above compounds.Type: GrantFiled: November 15, 2002Date of Patent: August 31, 2004Assignee: Bristol-Myers Squibb CompanyInventors: John Lloyd, Heather J. Finlay, Wayne Vaccaro, Karnail S. Atwal, Michael F. Gross, Kerry L. Spear
-
Patent number: 6783737Abstract: Multiple parallel chemical reactions are performed under pressure in a reactor including a multi-row array of reaction vessels situated between a temperature control base and a fluid flow manifold. The manifold consists of an input portion connected to the fluid supply by a five-way valve and a distribution portion which includes separate parallel distribution channels, one for each row of reaction vessels. A control valve for each distribution channel is interposed between the manifold portions such that the fluid flow to each row of reaction vessels can be independently controlled. An explosion proof transparent shield can be situated between the base and manifold, surrounding the reaction vessels. The interior of the shield can be flooded with inert gas.Type: GrantFiled: January 25, 2002Date of Patent: August 31, 2004Assignee: Bristol-Myers Squibb CompanyInventors: Joseph Nolfo, Maxine Soumellant, Victor W. Rosso, Peter Lee, Mayra B. Reyes, John J. Venit
-
Patent number: 6722403Abstract: A bifurcated bracket carries two powder dispensing assemblies. Each assembly includes a powder reservoir and a rotatable screw received within a compliant silicone sleeve. The outer diameter of the screw is slightly larger than the inner diameter of the sleeve such that the screw blade maintains direct contact with the sleeve wall as the screw is rotated. The bracket is sequentially moved to align each assembly with containers in two arrays. Each array of containers is situated in a tray. The trays are manually positioned on independent scales which generate signals that are a function of the sensed weight of each array. To fill each container, the screw in the aligned assembly is rotated at a high rate for an initial period and then at a slower rate. The scales are operational only during the slower rate period. Assembly movement and screw rotation are computer controlled.Type: GrantFiled: January 24, 2002Date of Patent: April 20, 2004Assignee: Bristol-Myers Squibb CompanyInventors: Peng Zhou, Edward Joseph Kuspiel, Waldemar Ruediger, Alexander Bertok, Carl J. Trpisovsky
-
Patent number: 6706720Abstract: Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.Type: GrantFiled: December 5, 2000Date of Patent: March 16, 2004Assignee: Bristol-Myers Squibb CompanyInventors: Karnail S. Atwal, Wayne Vaccaro, John Lloyd, Heather Finlay, Lin Yan, Rao S. Bhandaru
-
Patent number: 6639082Abstract: Methods for the preparation of biphenyl isoxazole sulfonamides and intermediates thereof. The present invention also relates to the novel intermediates prepared by these methods. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension.Type: GrantFiled: September 28, 2001Date of Patent: October 28, 2003Assignee: Bristol-Myers Squibb CompanyInventors: Richard P. Polniaszek, Xuebao Wang, John K. Thottathil, Theodor Denzel
-
Patent number: 6562994Abstract: The present invention provides an improved process for the preparation of N-(substituted phenyl)-3-alkyl-, aryl- and heteroarylsulfonyl-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds of formula I that exhibit antiandrogenic activity and are useful in the treatment of malignant or benign prostatic disease or of androgen dependent disease conditions such as acne, hirsutism or seborrhea.Type: GrantFiled: September 17, 2001Date of Patent: May 13, 2003Assignee: Bristol-Myers Squibb Co.Inventors: Bang-Chi Chen, Joseph E. Sundeen, Rulin Zhao
-
Patent number: 6177871Abstract: The present invention relates to a method for producing paperboard packaging (trays, lids, cartons, containers or combinations) with an integral RF-EAS security tag and a procedure for tuning the resonance frequency of the tag.Type: GrantFiled: July 28, 1999Date of Patent: January 23, 2001Assignee: Westvaco CorporationInventor: Paul B. Rasband